Optinate 30 mg Filmdragerad tablett

Land: Sverige

Språk: svenska

Källa: Läkemedelsverket (Medical Products Agency)

Köp det nu

Bipacksedel Bipacksedel (PIL)
22-04-2018
Produktens egenskaper Produktens egenskaper (SPC)
22-04-2018

Aktiva substanser:

risedronatnatrium

Tillgänglig från:

Theramex Ireland Limited

ATC-kod:

M05BA07

INN (International namn):

risedronate

Dos:

30 mg

Läkemedelsform:

Filmdragerad tablett

Sammansättning:

risedronatnatrium 30 mg Aktiv substans; laktosmonohydrat Hjälpämne

Klass:

Apotek

Receptbelagda typ:

Receptbelagt

Terapiområde:

Risedronsyra

Produktsammanfattning:

Förpacknings: Blister, 14 tabletter; Blister, 28 tabletter; Blister, 3 tabletter (startförpackning)

Bemyndigande status:

Godkänd

Tillstånd datum:

1999-10-07

Bipacksedel

                                Page 1 of 6
PACKAGE LEAFLET: INFORMATION FOR THE PATIENT
OPTINATE 30 MG FILM-COATED TABLETS
risedronate sodium
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE BECAUSE IT CONTAINS
IMPORTANT INFORMATION FOR YOU.

Keep this leaflet. You may need to read it again.

If you have any further questions, ask your doctor or pharmacist.

This medicine has been prescribed for you only. Do not pass it on to
others. It may harm them,
even if their signs of illness are the same as yours.

If you get any side effects, talk to your doctor or pharmacist. This
includes any possible side
effects not listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET
1.
What Optinate is and what it is used for
2.
What you need to know before you take Optinate
3.
How to take Optinate
4.
Possible side effects
5.
How to store Optinate
6.
Contents of the pack and other information
1.
WHAT OPTINATE IS AND WHAT IT IS USED FOR
WHAT OPTINATE IS
Optinate belongs to a group of non-hormonal medicines called
bisphosphonates which are used to treat
bone diseases. It works directly on your bones to make them stronger
and therefore less likely to
break.
Bone is a living tissue. Old bone is constantly removed from your
skeleton and replaced with new
bone.
Paget’s disease occurs when this process, called remodeling, happens
too quickly and in a disordered
way. The new bone that is produced is weaker than normal and the
affected bones may become
enlarged, painful and may fracture. Optinate changes the bone
remodeling process back to normal,
returning the strength to the bone structure.
WHAT OPTINATE IS USED FOR
Treatment of Paget’s disease of the bone (osteitis deformans).
2.
WHAT YOU NEED TO KNOW BEFORE YOU TAKE OPTINATE
DO NOT TAKE OPTINATE

If you are allergic
to risedronate sodium or any of the other ingredients of this medicine
(listed
in section 6)

If your doctor has told you that you have a condition called
hypocalcaemia (a low blood calcium
level)

If you may be pregnant, are pregnant or planning t
                                
                                Läs hela dokumentet
                                
                            

Produktens egenskaper

                                MARKNADSFÖRS EJ FÖR NÄRVARANDE.
_Produktinformation_
                                
                                Läs hela dokumentet
                                
                            

Dokument på andra språk

Bipacksedel Bipacksedel engelska 26-02-2020
Produktens egenskaper Produktens egenskaper engelska 18-10-2018